New drug shows promise for back pain from ankylosing spondylitis
Disease control
Completed
This study tested a new antibody drug (XKH004) in 323 adults with moderate-to-severe active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. The drug aims to reduce inflammation by blocking certain proteins. Participants received either the drug or…
Phase: PHASE3 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control
Last updated May 03, 2026 21:17 UTC